We are grateful that the New York Times found and reported on our research regarding the TB dosing guidelines in patients with living with HIV, and the fact that our findings show that the dosage guidelines may indeed be too low. The article was published in April, 2018 and can be found here: https://www.nytimes.com/2018/04/06/health/tuberculosis-treatment-hiv.html
Personal Insights Blog
R4GH team members share their personal insights with interested readers in the Personal Insights Blog.
Gestational diabetes mellitus in HIV-infected women
Diabetes mellitus (DM) is one of the most common non-communicable diseases worldwide. The number of people with diabetes is increasing rapidly, especially in sub-Saharan Africa....
Species Identification of Non-Tuberculous Mycobacteria in the Ugandan Population
Infections with non-tuberculous mycobacteria (NTM) are on the rise worldwide, directing the global focus to these lesser known organisms. NTM range from harmless microbes to...
The ALPHA Study
Amikacin Exposure and Toxicity – Pharmacokinetic Pharmacodynamic Analysis in Patients with Multidrug-Resistant Tuberculosis in Uganda : A Pilot Study Treatment of patients with multidrug-resistant TB...